The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program
Open accessAbstract
BACKGROUND: Australia's National Cervical Screening Program currently recommends cytological screening every 2 years for women aged 18-69 years. Human papillomavirus (HPV) vaccination was implemented in 2007 with high population coverage, and falls in high-grade lesions in young women have been reported extensively. This decline prompted a major review of the National Cervical Screening Program and new clinical management guidelines, for which we undertook this analysis. METHODS: We did effectiveness modelling and an economic assessment of potential new screening strategies, using a model of HPV transmission, vaccination, natural history, and cervical screening. First, we evaluated 132 screening strategies, including those based on cytology and primary HPV testing. Second, after a recommendation was made to adopt primary HPV screening with partial genotyping and direct referral to colposcopy of women positive for HPV16/18, we evaluated the final effect of HPV screening after incorporating new clinical guidelines for women positive for HPV. Both evaluations considered both unvaccinated and vaccinated cohorts. FINDINGS: Strategies entailing HPV testing every 5 years and either partial genotyping for HPV16/18 or cytological co-testing were the most effective. One of the most effective and cost-effective strategies comprised primary HPV screening with referral of women positive for oncogenic HPV16/18 direct to colposcopy, with reflex cytological triage for women with other oncogenic types and direct referral for those in this group with high-grade cytological findings. After incorporating detailed clinical guidelines recommendations, this strategy is predicted to reduce cervical cancer incidence and mortality by 31% and 36%, respectively, in unvaccinated cohorts, and by 24% and 29%, respectively, in cohorts offered vaccination. Furthermore, this strategy is predicted to reduce costs by up to 19% for unvaccinated cohorts and 26% for cohorts offered vaccination, compared with the current programme. INTERPRETATION: Primary HPV screening every 5 years with partial genotyping is predicted to be substantially more effective and potentially cost-saving compared with the current cytology-based screening programme undertaken every 2 years. These findings underpin the decision to transition to primary HPV screening with partial genotyping in the Australian National Cervical Screening Program, which will occur in May, 2017. FUNDING: Department of Health, Australia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Dillner, J., Rebolj, M., Birembaut, P., Petry, K.-U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., et al. (2008) · BMJ · doi:10.1136/bmj.a1754 · Cited by 629
Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 530
Tabrizi, S. N., Brotherton, J. M. L., Kaldor, J. M., Skinner, S. R., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Phillips, S., Cummins, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70841-2 · Cited by 301
Goldhaber‐Fiebert, J. D., Stout, N. K., Salomon, J. A., Kuntz, K. M., & Goldie, S. J. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn019 · Cited by 288
Kitchener, H. C., Gilham, C., Sargent, A., Bailey, A. C., Albrow, R., Roberts, C., Desai, M., Mather, J., Turner, A. J., Moss, S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.008 · Cited by 175
Kitchener, H. C., Canfell, K., Gilham, C., Sargent, A., Roberts, C., Desai, M., & Peto, J. (2014) · Health Technology Assessment · doi:10.3310/hta18230 · Cited by 152
Self-citationElfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142
Brotherton, J. M. L., Murray, S. L., Hall, M., Andrewartha, L., Banks, C., Meijer, D., Pitcher, H. C., Scully, M., & Molchanoff, L. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10272 · Cited by 141
Self-citation
Cited by
Sorted by citations
Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21628 · Cited by 968
Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 943
Self-citationCanfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T. N., Bénard, É., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30157-4 · Cited by 650
Self-citationSimms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J.-B., Soerjomataram, I., Castle, P. E., Bray, F., & Canfell, K. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30836-2 · Cited by 486
Self-citationThe projected timeframe until cervical cancer elimination in Australia: a modelling study
Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Brotherton, J. M. L., Saville, M., Frazer, I. H., & Canfell, K. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30183-x · Cited by 448
Self-citation2020 list of human papillomavirus assays suitable for primary cervical cancer screening
Arbyn, M., Simon, M., Peeters, E., Xu, L., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Bonde, J., Ostrbenk Vanlencak, A., Zhao, F.-H., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.04.031 · Cited by 284
Self-citationPalmer, T. J., Wallace, L., Pollock, K. G. J., Cuschieri, K. S., Robertson, C., Kavanagh, K., & Cruickshank, M. E. (2019) · BMJ · doi:10.1136/bmj.l1161 · Cited by 238
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Simms, K. T., Hanley, S. J. B., Smith, M. A., Keane, A., & Canfell, K. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30010-4 · Cited by 230
Self-citationKyrgiou, M., Arbyn, M., Bergeron, C., Bosch, F. X., Dillner, J., Jit, M., Kim, J., Poljak, M., Nieminen, P., Sasieni, P. D., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0920-9 · Cited by 168
Projected time to elimination of cervical cancer in the USA: a comparative modelling study
Burger, E. A., Smith, M. A., Killen, J., Sy, S., Simms, K. T., Canfell, K., & Kim, J. J. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30006-2 · Cited by 112
Self-citationSimms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105
Self-citationCanfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 100
Self-citationBowden, S. J., Kalliala, I. E. J., Veroniki, A. A., Arbyn, M., Mitra, A., Lathouras, K., Mirabello, L. J., Chadeau‐Hyam, M., Paraskevaidis, E. A., Flanagan, J. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.053 · Cited by 89
Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Saville, M., & Canfell, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0185332 · Cited by 80
Self-citationLožar, T., Nagvekar, R., Rohrer, C. T., Mandishora, R. S. D., Ivanuš, U., & Fitzpatrick, M. B. (2021) · International Journal of Women s Health · doi:10.2147/ijwh.s288376 · Cited by 74
Canfell, K., Kim, J. J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J. A., Campos, N., Jennett, C., Sharma, M., Simms, K. T., et al. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.100184 · Cited by 68
Self-citationLew, J., John, D. J. B. S., Macrae, F., Emery, J. D., Ee, H. C., Jenkins, M. A., He, E., Grogan, P. B., Caruana, M., Sarfati, D., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31314 · Cited by 66
Self-citationSmith, M. A., Sherrah, M., Sultana, F., Castle, P. E., Arbyn, M., Gertig, D. M., Caruana, M., Wrede, C. D., Saville, M., & Canfell, K. (2022) · BMJ · doi:10.1136/bmj-2021-068582 · Cited by 59
Self-citationEliminating Cervical Cancer: Progress and Challenges for High-income Countries
Davies, J. C., Smith, M. A., Grover, S., Canfell, K., & Crosbie, E. J. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.06.013 · Cited by 60
Self-citationLew, J., John, D., Macrae, F., Emery, J. D., Ee, H. C., Jenkins, M. A., He, E., Grogan, P. B., Caruana, M., Greuter, M. J. E., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0128 · Cited by 56
Self-citationMachalek, D. A., Roberts, J. M., Garland, S. M., Thurloe, J. K., Richards, A., Chambers, I., Sivertsen, T., & Farnsworth, A. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50223 · Cited by 54
Correa, R. M., Baena, A., Valls, J., Colucci, M. C., Mendoza, L. P., Rol, M., Wiesner, C., Ferrera, A., Fellner, M. D., González, J. V., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272205 · Cited by 58
Lew, J., Feletto, E., Wade, S. L., Caruana, M., Kang, Y., Nickson, C., Simms, K. T., Procopio, P., Taylor, N. J., Worthington, J., et al. (2019) · Public Health Research & Practice · doi:10.17061/phrp2921913 · Cited by 56
Self-citationWorthington, J., Feletto, E., Lew, J., Broun, K., Durkin, S. J., Wakefield, M. A., Grogan, P. B., HARPER, T. A., & Canfell, K. (2019) · Public Health · doi:10.1016/j.puhe.2019.10.003 · Cited by 49
Self-citationHuman Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer
Piña‐Sánchez, P. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.11.009 · Cited by 53
Lippman, S. M., Abate-Shen, C. T., Maresso, K. C., Colditz, G. A., Dannenberg, A. J., Davidson, N. E., Disis, M. L., DuBois, R. N., Szabo, E. M., Giuliano, A. R., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0421 · Cited by 48
Paraskevaidi, M., Cameron, S. J. S., Whelan, E., Bowden, S. J., Tzafetas, M., Mitra, A., Semertzidou, A., Athanasiou, A., Bennett, P. R., MacIntyre, D. A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103017 · Cited by 47
Shen, M., Zou, Z., Bao, H., Fairley, C. K., Canfell, K., Ong, J. J., Hocking, J. S., Chow, E. P. F., Zhuang, G., Wang, L., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100726 · Cited by 44
Self-citationAarnio, R., Östensson, E., Olovsson, M., Gustavsson, I. M., & Gyllensten, U. B. (2020) · BMC Cancer · doi:10.1186/s12885-020-07085-9 · Cited by 48
Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature
Liverani, C. A., Giuseppe, J. D., Giannella, L., Carpini, G. D., & Ciavattini, A. (2020) · Journal of Oncology · doi:10.1155/2020/8887672 · Cited by 45
Smith, M. A., Burger, E. A., Castañón, A., de Kok, I. M. C. M., Hanley, S. J. B., Rebolj, M., Hall, M. T., Jansen, E. E. L., Killen, J., O'Farrell, X., et al. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106623 · Cited by 43
Self-citationBayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
Bonde, J. H., Bottari, F., Parvu, V., Pedersen, H., Yanson, K. A., Iacobone, A. D., Kodsi, S., Landoni, F., Vaughan, L. M., Ejegod, D. M., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32291 · Cited by 36
Mac, O. A., Thayre, A., Tan, S., & Dodd, R. H. (2020) · Journal of Medical Internet Research · doi:10.2196/16701 · Cited by 35
Levi, J. E., Martins, T. R., Longatto‐Filho, A., Cohen, D. D., Cury, L., Fuza, L. M., Villa, L. L., & Eluf‐Neto, J. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0076 · Cited by 40
Onuma, T., Kurokawa, T., Shinagawa, A., Chino, Y., & Yoshida, Y. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01727-5 · Cited by 38
Wang, J., Staheli, J. P., Wu, A., Kreutz, J. E., Hu, Q., Wang, J., Schneider, T., Fujimoto, B. S., Qin, Y., Yen, G. S., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04973 · Cited by 35
Morrow, A., Hogden, E., Kang, Y., Steinberg, J., Canfell, K., Solomon, M. J., Kench, J. G., Gill, A. J., Shaw, T. J., Pachter, N., et al. (2019) · Trials · doi:10.1186/s13063-019-3457-6 · Cited by 34
Self-citationUpdated evidence-based recommendations for cervical cancer screening in France
Hamers, F. F., Poullié, A.-I., & Arbyn, M. (2021) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000701 · Cited by 36
Smith, M. A., Hall, M. T., Saville, M., Brotherton, J. M. L., Simms, K. T., Lew, J., Bateson, D. J., Skinner, S. R., Kelaher, M., & Canfell, K. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0998 · Cited by 33
Self-citationNguyen, D., Simms, K. T., Keane, A., Mola, G., Bolnga, J. W., Kuk, J., Toliman, P. J., Badman, S. G., Saville, M., Kaldor, J. M., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007380 · Cited by 34
Self-citationSultana, F., Roeske, L., Malloy, M. J., McDermott, T. L., Saville, M., & Brotherton, J. M. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228042 · Cited by 33
Self-citationCanfell, K., Saville, M., Caruana, M., Gebski, V., Darlington-Brown, J., Brotherton, J. M. L., Heley, S., & Castle, P. E. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016700 · Cited by 30
Self-citationCampos‐Romero, A., Anderson, K. S., Longatto‐Filho, A., Esparza, M. A. L.-R., Moran-Portela, D. D. J., Castro-Menéndez, J. A., Moreno-Camacho, J. L., Calva-Espinosa, D. Y., Acosta-Alfaro, M. A., Mejía, F. A. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46543-8 · Cited by 30
Hall, M. T., Smith, M. A., Simms, K. T., Barnabas, R. V., Canfell, K., & Murray, J. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231388 · Cited by 34
Self-citationMcGregor, S., Saulo, D., Brotherton, J. M. L., Liu, B. C., Phillips, S., Skinner, S. R., Luey, M., Oliver, L., Stewart, M., Tabrizi, S. N., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.104 · Cited by 29
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV
Hall, M. T., Simms, K. T., Murray, J. M., Keane, A., Nguyen, D. T. N., Caruana, M., Lui, G., Kelly, H. A., Eckert, L. O., Santesso, N. A., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02601-3 · Cited by 30
Self-citationVelentzis, L. S., Caruana, M., Simms, K. T., Lew, J., Shi, J., Saville, M., Smith, M. A., Lord, S. J., Tan, J., Bateson, D. J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30926 · Cited by 26
Self-citationFogelberg, S., Clements, M., Pedersen, K., Sy, S., Sparén, P., Kim, J. J., & Burger, E. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239611 · Cited by 26
O’Connor, M., O’Leary, E., Waller, J., Gallagher, P., Martin, C. M., O’Leary, J. J., & Sharp, L. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.08.017 · Cited by 24
Lew, J., Greuter, M. J. E., Caruana, M., He, E., Worthington, J., John, D. J. S., Macrae, F., Feletto, E., Coupé, V. M. H., & Canfell, K. (2020) · Medical Decision Making · doi:10.1177/0272989x20944869 · Cited by 24
Self-citationGottschlich, A., van Niekerk, D., Smith, L., Gondara, L., Melnikow, J. A., Cook, D. A., Lee, M. H., Stuart, G. C. E., Martin, R. E., Peacock, S. J., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1177 · Cited by 25
A systematic review of economic evaluations of cervical cancer screening methods
Sefuthi, T., & Nkonki, L. L. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02017-z · Cited by 26
Keane, A., Ng, C., Simms, K. T., Nguyen, D., Woo, Y. L., Saville, M., & Canfell, K. (2021) · International Journal of Cancer · doi:10.1002/ijc.33759 · Cited by 26
Self-citationMalagón, T., Volesky, K. D., Bouten, S., Laprise, C., El‐Zein, M., & Franco, E. L. (2020) · International Journal of Cancer · doi:10.1002/ijc.33035 · Cited by 23
Chadwick, V. L., Bennett, K. F., McCaffery, K. J., Brotherton, J. M. L., & Dodd, R. H. (2022) · Psycho-Oncology · doi:10.1002/pon.5897 · Cited by 21
Chan, D. N. S., Law, B. M. H., So, W. K. W., & Fan, N. (2022) · Health Policy · doi:10.1016/j.healthpol.2022.08.003 · Cited by 21
Chen, Y., Li, S., Zheng, J., Xue, H., Chen, J., & Zheng, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28062 · Cited by 21
Spotlight on the role of human papillomavirus vaccines
Bogani, G., Raspagliesi, F., Donato, V. D., Brusadelli, C., Guerrisi, R., Pinelli, C., Casarin, J., Ghezzi, F., Fabro, A. D., Ditto, A., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.08.034 · Cited by 21
Pedersen, K., Kristiansen, I. S., Sy, S., Kim, J. J., & Burger, E. A. (2023) · Value in Health · doi:10.1016/j.jval.2023.04.005 · Cited by 20
Ruan, Y., Li, H., Liu, M., Cao, G., Xu, X., Han, L., & Li, F. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102372 · Cited by 20
Self-citationFreko, S., Nikić, M., Mayer, D., Weiß, L. J. K., Simmel, F. C., & Wolfrum, B. L. (2024) · ACS Sensors · doi:10.1021/acssensors.4c02060 · Cited by 20
Current Status of and Perspectives on Cervical Cancer Screening in Korea
Lim, S., & Yoo, C. W. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.04.11 · Cited by 19
Dasgupta, P., Aitken, J. F., Condon, J. R., Garvey, G., Whop, L. J., DeBats, C., & Baade, P. D. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101849 · Cited by 19
Jaenke, R., Butler, T., Condon, J. R., Garvey, G., Brotherton, J. M. L., Cunningham, J., Anderson, K. M., Tong, A., Moore, S., & Whop, L. J. (2021) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.13084 · Cited by 17
Inturrisi, F., Lissenberg-Witte, B. I., Veldhuijzen, N. J., Bogaards, J. A., Ronco, G., Meijer, C. J. L. M., & Berkhof, J. H. (2020) · International Journal of Cancer · doi:10.1002/ijc.33207 · Cited by 16
Obermair, H., Bennett, K. F., Brotherton, J. M. L., Smith, M. A., McCaffery, K. J., & Dodd, R. H. (2021) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13310 · Cited by 17
Self-citationCervical cancer: Challenges and prevention strategies: A narrative review
Tsige, A. W., & Beyene, D. A. (2024) · Health Science Reports · doi:10.1002/hsr2.2149 · Cited by 16
Velentzis, L. S., Smith, M. A., Simms, K. T., Lew, J., Hall, M. T., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K. A., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.019 · Cited by 16
Self-citationAlfaro, K. M., Maza, M., Felix, J. C., Gage, J. C., Castle, P. E., Alonzo, T. A., Chacón, A., González, E., Soler, M., Rodriguez, G. C., et al. (2020) · JCO Global Oncology · doi:10.1200/go.20.00206 · Cited by 20
Skroumpelos, A., Αγοραστός, Θ., Constantinidis, T. C., Chatzistamatiou, Κ., & Kyriopoulos, J. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226335 · Cited by 16
Choi, C., Leung, K. S. M., Chan, K. K. L., Bai, Y., Jit, M., & Wu, J. T. K. (2023) · BMC Medicine · doi:10.1186/s12916-023-02748-3 · Cited by 16
Ma, X., Harripersaud, K., Smith, M. K., Fairley, C. K., Zou, H., Zou, Z., Wang, Y., Zhuang, G., & Zhang, L. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1832835 · Cited by 14
Self-citationCromwell, I., Smith, L., van der Hoek, K., Hedden, L., Coldman, A. J., Cook, D. A., Franco, E. L., Krajden, M., Martin, R. E., Lee, M. H., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3864 · Cited by 15
Dong, B., Zou, H., Mao, X., Su, Y., Gao, H., Xie, F., Lv, Y., Chen, Y., Kang, Y., Xue, H., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211010939 · Cited by 15
Self-citationTerada, N., Matsuura, M., Kurokawa, S., Nishimura, Y., Tamate, M., Isoyama, K., Yamazaki, S., Shimada, H., Suzuki, M., Tabuchi, Y., et al. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02238-1 · Cited by 14
Kassymbekova, F., Rommel, A., Kaidarova, D., Auyezova, A. M., Nukusheva, S., Dunenova, G., Bolatbekova, R., Жетписбаева, И. А., Abdushukurova, G., & Glushkova, N. (2024) · Vaccines · doi:10.3390/vaccines12111225 · Cited by 13
Brotherton, J. M. L., Vajdic, C. M., & Nightingale, C. E. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2451732 · Cited by 14
Yang, X., You, Q., Yao, G., Geng, J., Ma, R., & Meng, H. (2020) · Cancer Management and Research · doi:10.2147/cmar.s262678 · Cited by 13
Implementing changes to cervical screening: A qualitative study with health professionals
Dodd, R. H., Obermair, H., & McCaffery, K. J. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13200 · Cited by 13
de Bondt, D. D., Naslazi, E., Jansen, E. E. L., Kupets, R., McCurdy, B. R., Stogios, C., de Kok, I. M. C. M., & Hontelez, J. A. C. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.03.008 · Cited by 12
Tsakogiannis, D., Zografos, E., Tzioga, L., Zografos, C. G., Zagouri, F., & Bletsa, G. (2025) · Cancers · doi:10.3390/cancers17081267 · Cited by 14
Cervical screening in HPV-vaccinated populations
Canfell, K. (2018) · Climacteric · doi:10.1080/13697137.2018.1428296 · Cited by 12
Self-citationHall, M. T., Hyatt, A., Smith, M. A., Torode, J., Costa, T., Nguyen, D., Balshaw, T., Grogan, P. B., Sweeny, K., Auste, C., et al. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101423 · Cited by 13
Self-citationBrotherton, J. M. L., McDermott, T. L., Smith, M. A., Machalek, D. A., Shilling, H. S., Prang, K.-H., Jennett, C. J., Nightingale, C. E., Zammit, C. M., Pagotto, A., et al. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102213 · Cited by 11
Self-citationBowden, S. J., Ellis, L. B., Kalliala, I. E. J., Paraskevaidi, M., Tighe, J., Kechagias, K. S., Doulgeraki, T., Paraskevaidis, E. A., Arbyn, M., Flanagan, J. M., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071534 · Cited by 11
He, Z., Zheng, X., Liu, R., Zhao, K., Mao, D., Zhang, L., Wan, R., Zhang, H., & Wang, X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s524518 · Cited by 12
Smith, M. A., Hall, M. T., Lew, J., & Canfell, K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.063 · Cited by 12
Self-citationMartellucci, C. A., Morettini, M., Brotherton, J. M. L., Canfell, K., Manzoli, L., Flacco, M. E., Palmer, M., Rossi, P. G., Martellucci, M., Giacomini, G., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0895 · Cited by 11
Self-citationA new era for cervical screening in Australia: Watch this space!
Hammond, I. G., Canfell, K., & Saville, M. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12669 · Cited by 11
Self-citationHuang, Y., Sun, L., Liu, W., Yang, L., Song, Z., Ning, X., Li, W., Tan, M., Yu, Y., & Li, Z. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341050 · Cited by 11
Hall, M. T., Smith, M. A., Lew, J., O’Hallahan, J., Fentiman, G., Neal, H., Sage, M., & Canfell, K. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.045 · Cited by 12
Self-citationFeletto, E., Lew, J., Worthington, J., He, E., Caruana, M., Butler, K. A., Hui, H., Taylor, N. J., Banks, E., Barclay, K., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036475 · Cited by 10
Self-citationEnsuring quality in cervical screening programmes based on molecular human papillomavirus testing
Cuschieri, K. S., Schuurman, R., & Coughlan, S. (2019) · Cytopathology · doi:10.1111/cyt.12679 · Cited by 10
Health economic evaluation of primary human papillomavirus screening in urban populations in China
Keane, A., Shi, J., Simms, K. T., Liu, Y., Lew, J., Mazariego, C. G., Yuill, S., Wu, R., Liu, Z., Zhao, F., et al. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101861 · Cited by 11
Self-citationSrisuttayasathien, M., Kantathavorn, N., Luasiripanthu, T., Petchjorm, S., Samrarn, J., Ittiamornlert, P., Krisorakun, W., Vanichtantikul, A., Wetcho, T., & Saeloo, S. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2024.01.014 · Cited by 9
Self‐collection for HPV screening: a game changer in the elimination of cervical cancer
Canfell, K., Smith, M. A., & Bateson, D. J. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51262 · Cited by 9
Self-citationRodriguez, N. M., Brennan, L. P., Claure, L. A., Balian, L. N., Kasting, M. L., Champion, V. L., & Forman, M. R. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.102070 · Cited by 8
Meta-analysis of downregulated E-cadherin as a diagnostic biomarker for cervical cancer
Ma, X., Ge, A., Han, J., Kang, J., Zhang, Y., Liu, X., Xing, L., Liu, X., & Dong, L. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06475-7 · Cited by 9
Should Cervical Cancer Screening be Performed Before the Age of 25 Years?
Moscicki, A., Perkins, R. B., Saville, M., & Brotherton, J. M. L. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000434 · Cited by 7
Self-citationPerformance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial
Hu, S., Kreimer, A. R., Porras, C., Guillén, D., Alfaro, M., Darragh, T. M., Stoler, M. H., Villegas, L. F., Ocampo, R., Rodríguez, A. C., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac107 · Cited by 7
Metadata
- Authors
- Lew, J.-B., Simms, K. T., Smith, M. A., Hall, M., Kang, Y.-J., Xu, X. M., Caruana, M., Velentzis, L. S., Bessell, T., Saville, M., Hammond, I., & Canfell, K.
- Affiliations
- Cancer Council NSW (AU)
- The University of Sydney (AU)
- Department of Health and Aged Care (AU)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Corresponding author
- Canfell, Karen
- ORCID
- Venue
- The Lancet Public Health
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 2
- Issue
- 2
- Pages
- e96-e107
- ISSN
- 2468-2667 (ISSN-L)
- OpenAlex
- W2586260676
- Cited by
- 160
- References
- 26
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 13 · 2022: 17 · 2021: 19 · 2020: 32 · 2019: 25 · 2018: 19 · 2017: 6
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Lancet Public Health (publishedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- Multiple System Atrophy Coalition
- National Health and Medical Research Council (1082989, 440200, 1007518)
- Cancer Council NSW
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- primary HPV testing, cervical cancer screening, HPV vaccination, HPV genotyping, HPV 16/18, colposcopy referral, cervical cancer incidence and mortality, cost-effectiveness, National Cervical Screening Program
- MeSH terms
- Adolescent, Adult, Aged, Australia, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Cell Biology, Diagnostic Tests, Routine, Female, Humans, Middle Aged, Primary Prevention, Program Evaluation, Papillomavirus Infections, Papillomavirus Vaccines, Early Detection of Cancer, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
